Clinical study of astragalus injection combined with marine injection treatment in patients with decompensated cirrhosis
AIM:To observe the clinical effects of astragalus injection combined with Marine injection treatment in patients with decompensated cirrhosis.METHODS:Eighty cases patients with decompensated cirrhosis were randomly divided into the treatment group and the control group.On the basis of conventional treatment,the treatment group was given the another astragalus injection 40 mL intravenous drip and Marine Injection 6 mL intravenous drip,1 times a day for 3 months,the control group was given conventional therapy,and observation of the changes and treatment of laboratory results.RESULTS:In the treatment group,the liver function indicators ALT,AST,TBIL,ALB than before treatment have significantly improved(P＜0.05),the control group only ALT,AST hasimproved(P＜0.05);indicators of the level of liver fibrosis,in the control group,after treatment than before treatment decreased significantly(P＜0.05),but also significantly lower than the control group after treatment(P＜0.05);the total efficiency of 92.5% in the treatment group.but the total efficiency of 67.5%only in the control group.were more significant difference (P＜0.05);no adverse reaction.CONCLUSION:Astragalus injection combined with marine injection could control decompensated cirrhosis of the inflammation,fibrosis of the role of treatment significantly,with no adverse reaction in the 2 groups,woahy of clinical application.
NETL
NSTL
万方数据
维普
